Network Pharmacology-Based Analysis of the Potential Biological Mechanisms of Coix Seed Against Colorectal Cancer

Overview

Journal Evid Based Complement Alternat Med

Specialty Rehabilitation Medicine

Date 2022 Oct 17

PMID 36248436

Authors

Yi Sun

Peishi Jiang

Hongjie Yang

Zhichun Zhang

Yuanda Zhou

Peng Li

Qingsheng Zeng

Xipeng Zhang

Affiliations

Soon will be listed here.

Abstract

Objective: The aim of this study was to explore the potential biological mechanisms of coix seed in the treatment of colorectal cancer (CRC) based on network pharmacology analysis.

Methods: The active components of coix seed and their potential action targets were retrieved from Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform(TCMSP). The disease targets related to CRC were obtained from the DisGeNET database. The intersection targets of the drug targets and disease targets were selected, and a component-target-disease network was built using Cytoscape 3.8.0 tool. A global network of the core target protein interactions was constructed using String database. Biological function analysis and pathway enrichment analysis of core targets were conducted to explore the potential.

Results: A total of nine active components were obtained from the TCMSP database corresponding to 37 targets. Further analysis showed that 18 overlapping targets were associated with CRC. Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis was conducted based on the 18 targets and 11 significantly enriched signaling pathways implicated in CRC were identified.

Conclusion: The multicomponent and multitarget characteristics of coix seed are preliminarily verified, and the potential biological mechanisms of coix seed in the treatment of CRC are predicted, which provides a theoretical basis for the experimental research.

Citing Articles

Targeting colorectal cancer with Herba Patriniae and Coix seed: Network pharmacology, molecular docking, and validation.

Wang C, Yang B, Wang X, Chen X, Li W, Zhai H World J Gastrointest Oncol. 2024; 16(8):3539-3558.

PMID: 39171161 PMC: 11334031. DOI: 10.4251/wjgo.v16.i8.3539.

References

Sayeed M, Ameen S . Beta-Sitosterol: A Promising but Orphan Nutraceutical to Fight Against Cancer. Nutr Cancer. 2015; 67(8):1214-20. DOI: 10.1080/01635581.2015.1087042. View

Zhang Y, Wen X, Guo X, Huang S, Wang T, Zhou P . Progesterone suppresses the progression of colonic carcinoma by increasing the activity of the GADD45α/JNK/c‑Jun signalling pathway. Oncol Rep. 2021; 45(6). PMC: 8054317. DOI: 10.3892/or.2021.8046. View

Yadav V, Sharma K, Bhattacharya S, Talwar P, Purohit P, Saini N . RETRACTED: hsa-miR-23a~27a~24-2 cluster members inhibit aggressiveness of breast cancer cells by commonly targeting NCOA1, NLK and RAP1B. Life Sci. 2022; 307:120906. DOI: 10.1016/j.lfs.2022.120906. View

Kunzmann A, Murray L, Cardwell C, McShane C, McMenamin U, Cantwell M . PTGS2 (Cyclooxygenase-2) expression and survival among colorectal cancer patients: a systematic review. Cancer Epidemiol Biomarkers Prev. 2013; 22(9):1490-7. DOI: 10.1158/1055-9965.EPI-13-0263. View

Chen H, Lo Y, Chiang W . Inhibitory effects of adlay bran (Coix lachryma-jobi L. var. ma-yuen Stapf) on chemical mediator release and cytokine production in rat basophilic leukemia cells. J Ethnopharmacol. 2012; 141(1):119-27. DOI: 10.1016/j.jep.2012.02.009. View

Xiu X, Sun Y, Wu Y, Jin K, Qu L, Liu Y . Modular remodeling of sterol metabolism for overproduction of 7-dehydrocholesterol in engineered yeast. Bioresour Technol. 2022; 360:127572. DOI: 10.1016/j.biortech.2022.127572. View

Yu J, Wu W, Liang Q, Zhang N, He J, Li X . Disruption of NCOA2 by recurrent fusion with LACTB2 in colorectal cancer. Oncogene. 2015; 35(2):187-95. PMC: 4717154. DOI: 10.1038/onc.2015.72. View

Mrdenovic D, Ge W, Kumar N, Zenobi R . Nanoscale Chemical Imaging of Human Cell Membranes Using Tip-Enhanced Raman Spectroscopy. Angew Chem Int Ed Engl. 2022; 61(43):e202210288. PMC: 9826433. DOI: 10.1002/anie.202210288. View

Ru J, Li P, Wang J, Zhou W, Li B, Huang C . TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 2014; 6:13. PMC: 4001360. DOI: 10.1186/1758-2946-6-13. View

10.

Xiang Y, Guo Z, Zhu P, Chen J, Huang Y . Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science. Cancer Med. 2019; 8(5):1958-1975. PMC: 6536969. DOI: 10.1002/cam4.2108. View

11.

Zheng H, Zhang W, Zhou H, Zhang W, Yu J, Wang W . [Effect of Coixenolide on Foxp3+ CD4+ CD25+ Regulatory T Cells in Collagen-induced Arthritis Mice]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2016; 36(3):348-50. View

12.

Zhang D, Wu J, Duan X, Wang K, Ni M, Liu S . Network Meta-Analysis of Chinese Herbal Injections Plus the FOLFOX Regimen for the Treatment of Colorectal Cancer in China. Integr Cancer Ther. 2019; 18:1534735419827098. PMC: 7242776. DOI: 10.1177/1534735419827098. View

13.

Dong Y, Chen C, Chen C, Zhang C, Zhang L, Zhang Y . Stigmasterol inhibits the progression of lung cancer by regulating retinoic acid-related orphan receptor C. Histol Histopathol. 2021; 36(12):1285-1299. DOI: 10.14670/HH-18-388. View

14.

Mao W, Fan Y, Cheng C, Yuan X, Lan T, Mao K . Efficacy and safety of Kanglaite injection combined with chemotherapy for colorectal cancer: A protocol for systematic review and meta-analysis. Medicine (Baltimore). 2020; 99(39):e22357. PMC: 7523838. DOI: 10.1097/MD.0000000000022357. View

15.

Bae H, Song G, Lim W . Stigmasterol Causes Ovarian Cancer Cell Apoptosis by Inducing Endoplasmic Reticulum and Mitochondrial Dysfunction. Pharmaceutics. 2020; 12(6). PMC: 7356731. DOI: 10.3390/pharmaceutics12060488. View

16.

Arredondo E, Dumbauld J, Milla M, Madanat H, Coronado G, Haughton J . A -Led Pilot Study to Increase Colorectal Cancer Screening in Latinos: The Program. Health Promot Pract. 2020; 22(4):491-501. PMC: 8364826. DOI: 10.1177/1524839920912240. View

17.

Jinnouchi M, Miyahara T, Suzuki Y . Coix Seed Consumption Affects the Gut Microbiota and the Peripheral Lymphocyte Subset Profiles of Healthy Male Adults. Nutrients. 2021; 13(11). PMC: 8618347. DOI: 10.3390/nu13114079. View

18.

Wu C, Lee C, Ho Y . Nicotinic acetylcholine receptor-based blockade: applications of molecular targets for cancer therapy. Clin Cancer Res. 2011; 17(11):3533-41. DOI: 10.1158/1078-0432.CCR-10-2434. View

19.

Zhao H, He M, Zhang M, Sun Q, Zeng S, Chen L . Colorectal Cancer, Gut Microbiota and Traditional Chinese Medicine: A Systematic Review. Am J Chin Med. 2021; 49(4):805-828. DOI: 10.1142/S0192415X21500385. View

20.

Hernandez-Ceja A, Loeza-Lara P, Espinosa-Garcia F, Garcia-Rodriguez Y, Medina-Medrano J, Gutierrez-Hernandez G . In Vitro Antifungal Activity of Plant Extracts on Pathogenic Fungi of Blueberry ( sp.). Plants (Basel). 2021; 10(5). PMC: 8145869. DOI: 10.3390/plants10050852. View